Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (411-420 of 610) with videos related to

Pageof 61
Sort By:
Blood Advances|October 17, 2022
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16Tanja A Gruber, Deqing Pei, John Choi, et al.
JAMA Network Open|November 20, 2020
Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy OnlyNicholas S Phillips, Shelli R Kesler, Matthew A Scoggins, et al.
JAMA|October 22, 2002
Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemiaScott C Howard, Amar J Gajjar, Cheng Cheng, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Pharmacogenomics|April 1, 2011
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypesJatinder K Lamba, Kristine R Crews, Stanley B Pounds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2019
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational StudyChing-Hon Pui, Paola Rebora, Martin Schrappe, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Blood|September 5, 2008
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang, Deepa Bhojwani, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemiaHiroto Inaba, Jeffrey E Rubnitz, Elaine Coustan-Smith, et al.
Blood|May 27, 2011
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemiaWing Leung, Dario Campana, Jie Yang, et al.
Pageof 61

Showing results (411-420 of 610) with videos related to

Sort By:
Pageof 61
Blood Advances|October 17, 2022
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16Tanja A Gruber, Deqing Pei, John Choi, et al.
JAMA Network Open|November 20, 2020
Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy OnlyNicholas S Phillips, Shelli R Kesler, Matthew A Scoggins, et al.
JAMA|October 22, 2002
Risk factors for traumatic and bloody lumbar puncture in children with acute lymphoblastic leukemiaScott C Howard, Amar J Gajjar, Cheng Cheng, et al.
Journal for Immunotherapy of Cancer|March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemiaRosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Pharmacogenomics|April 1, 2011
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypesJatinder K Lamba, Kristine R Crews, Stanley B Pounds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2019
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational StudyChing-Hon Pui, Paola Rebora, Martin Schrappe, et al.
Journal of the National Cancer Institute|May 16, 2022
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic LeukemiaXujie Zhao, Maoxiang Qian, Charnise Goodings, et al.
Blood|September 5, 2008
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang, Deepa Bhojwani, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemiaHiroto Inaba, Jeffrey E Rubnitz, Elaine Coustan-Smith, et al.
Blood|May 27, 2011
High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemiaWing Leung, Dario Campana, Jie Yang, et al.
Pageof 61